https://www.avient.com/sites/default/files/2021-01/avient-colorants-sweden-ab-certificate-of-registration.pdf
120,000 BOARD MEMBER, MANAGING DIRECTOR 660613-3954 Nilsson, Bo Patrik Joakim, Hovslagaregatan 13, 271 57 YSTAD BOARD MEMBER, CHAIR OF THE BOARD 640503 Merklein, Norbert, Fichtenstrasse 20, 61476 KRONBERG IM TAUNUS, TYSKLAND BOARD MEMBERS 750618-4089 Norén, Jenny Eva Kristina, Fårabäcksvägen 68, 212 91 MALMÖ 610322 Smeds, Jan-Håkan, Chämiweg 23, NEFTENBACH, TYSKLAND AUDITORS 556029-6740 Öhrlings PricewaterhouseCoopers AB, Box 4009, 203 11 MALMÖ Represented by: 710921-4689 PRINCIPALLY RESPONSIBLE AUDITOR 710921-4689 Olsson, Karin Maria, c/o PwC, 405 32 GÖTEBORG SIGNATORY POWER e-Certificate of registration Swedish Companies Registration Office LIMITED COMPANY D1a- 6064988 Registration number Date of registration of the company Document created on Date of registration of current name Page 556393-1020 1990-04-10 2020-11-30 14:53 2020-11-30 2 (2) The board of directors is entitled to sign.
https://www.avient.com/sites/default/files/resources/POL%2520Sidoti%2520IR%2520Presentation%2520w%2520Non%2520GAAP%25203%252018%25202014.pdf
Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation Page 4 • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth • 17 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Steve Newlin Appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2013 2014 and beyond -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $38.38 March 7th, 2014 • 17 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 5 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% United States 66% Europe 14% Canada 7% Asia 6% Latin America 7% PP&S 20% Specialty 53% Distribution 27% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target Ad ju st ed E ar ni ng s P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 6 PolyOne At A Glance Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty Specialty OI $5M $46M $87M $195M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 2013 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.2% 12 – 16% Global Specialty Engineered Materials 1.1% 9.3% 12 – 16% Designed Structures & Solutions -- 5.6% 8 – 10% Performance Products & Solutions 5.4% 7.2% 9 – 12% Distribution 2.6% 5.9% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 62% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.1% 15% 4) Adjusted EPS Growth N/A 31% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 Bridge To $2.50 Adjusted EPS By 2015 2015 EPS: $2.50 2013 EPS: $1.31 Mid single digit revenue CAGR Page 9 Mergers & Acquisitions Spartech accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 10 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Healthcare Consumer Packaging and Additive Technology Transportation Page 11 Unique and Innovative Solutions that Help Customers Win https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG Net Debt / EBITDA* = 1.8x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of December 31, 2013 ($ millions) Page 12 Coupon Rates: 7.500% 7.375% 5.250% Debt Maturities & Pension Funding – 12/31/13 *TTM 12/31/2013 ** includes US-qualified plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2013 Pension Funding** As of December 31, 2013 Free Cash Flow and Strong Balance Sheet Fund Investment •Targets that expand our: • Specialty offerings •End market presence •Geographic footprint •Operating Margin • Synergy opportunities •Adjacent material solutions •Expanding our sales, marketing, and technical capabilities • Investing in operational and LSS initiatives (including synergy capture) •Manufacturing alignment Organic Growth Share Repurchases Dividends Acquisitions Page 13 $0.16 $0.20 $0.24 $0.32 $0.00 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend • Repurchased ~5 million shares in 2013 • 15 million shares are available for repurchase under the current authorization The New PolyOne: A Specialty Growth Company 2015 Target: $2.50 Adjusted EPS Why Invest In PolyOne?
PolyOne Investor Presentation��Sidoti & Company �Eighteenth Annual Emerging Growth �Institutional Investor Forum�March 18, 2014� Forward – Looking Statements Use of Non-GAAP Measures PolyOne Commodity to Specialty Transformation Strategy and Execution Drive Results PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Bridge To $2.50 Adjusted EPS By 2015 Innovation Drives Earnings Growth Unique and Innovative Solutions that Help Customers Win Debt Maturities & Pension Funding – 12/31/13 Free Cash Flow and Strong Balance Sheet Fund Investment Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2023-11/AVNT Q3 2023 Earnings Presentation - Website.pdf
GUIDANCE $800 $754 Guidance Actual $128 $123 Guidance Actual Sales Adjusted EBITDA (in millions) $0.56 $0.57 Guidance Actual Adjusted EPS (in millions) 9 • Demand impacted by destocking and cautious customer sentiment • Positive net price benefit: o CAI - Pricing flat and raw material deflation o SEM - Pricing flat with unfavorable mix related to healthcare, more than offset with raw material deflation • Cost reductions driven by Clariant synergies and reduced administrative costs Q3 EBITDA BRIDGE ($ millions) CAI: Price / Mix -) Deflation 22) SEM: Price / Mix (6) Deflation 13) Net Price Benefit 29) Cost Reductions 13) Wage Inflation (8) FX 1) Q3 2023 Actual $ 123) Adjusted EBITDA Q3 2022 Pro Forma $ 137) Demand (49) 10 2023 G U I DAN CE Q4 2023 GUIDANCE VS.
PRIOR YEAR $790 $710 2022 2023 $107 $112 2022 2023 Sales Adjusted EBITDA (in millions) $0.42 $0.47 2022 PF 2023 Adjusted EPS (in millions) - 10% + 5% + 12% Sales Adjusted EBITDA Adjusted EPS 12 $112 $500 Q4 FY $0.47 $2.30 Q4 FY Q4 AND FULL YEAR 2023 GUIDANCE $710 $3,130 Q4 FY Sales Adjusted EBITDA Adjusted EPS 13 (in millions) (in millions) Guidance: Free Cash Flow $180 $180 Prior Guidance Guidance FREE CASH FLOW & INCREASED DIVIDEND 13th Consecutive Dividend Increase 0.16 0.26 0.42 0.58 0.79 0.85 0.99 1.03 2011 2013 2015 2017 2019 2021 2023 2024 14 S U S TAI NABI L I T Y DAY RE CAP SUSTAINABILITY AS A GROWTH DRIVERLONG-TERM REVENUE GROWTH DRIVERS 60%+ Key Growth Drivers Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other (GDP Growth) Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other (GDP growth) 0–2% Avient 6% 17 SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 8-12% Long Term Growth 50 90 2022 2030 Medical Plastics Market Size (in $Billions) 2020 2030 Recycled Plastics Virgin Plastics Growing Demand for Recycled Content Avient Sustainable Solutions 18 46 2023 2032 Global Offshore Annual Wind Installations (in Gigawatts) Sources: McKinsey, Bloomberg, Grand View Research SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 18 • Transformative acquisitions combined with divestitures of more cyclical businesses have improved margins over 400 bps since 2018 • 20% long-term margin goal to be driven by key growth drivers, with sustainable solutions playing a meaningful role 5.4% 11.5% 16.0% 2006 2018 2023E Recovery Growth Drivers Strategic Objective 20%+ +1%+ +3%+ ADJUSTED EBITDA MARGIN EXPANSION 19 • 6% annualized long-term sales growth leveraging sustainable solutions, composites, healthcare, and emerging regions • Expand EBITDA margins to 20% • Deliver annual EBITDA and EPS growth of 10% and 15% • Maintain asset-light, 80% free cash flow conversion profile and be valued as a specialty formulator • Continue fostering our Great Place to Work® culture CREATING A WORLD-CLASS SUSTAINABLE ORGANIZATION 20 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
Three Months Ended September 30, 2023 Three Months Ended September 30, 2022 Reconciliation to Condensed Consolidated Statements of Income: $ EPS $ EPS Net income (loss) from continuing operations attributable to Avient shareholders $ 5.1 $ 0.06 $ (27.4) $ (0.30) Special items, after tax 32.0 0.35 68.3 0.75 Amortization expense, after-tax 15.2 0.16 $ 13.4 $ 0.14 Adjusted net income / EPS $ 52.3 $ 0.57 $ 54.3 $ 0.59 Three Months Ended September 30, Reconciliation to EBITDA and Adjusted EBITDA: 2023 2022 Sales - GAAP $ 753.7 $ 823.3 Pro Forma APM adjustments — 60.7 Pro forma adjusted sales $ 753.7 $ 884.0 Net income from continuing operations – GAAP $ 5.1 $ (27.8) Income tax (benefit) expense (0.1) (1.2) Interest expense, net 30.3 37.3 Depreciation and amortization 46.4 39.8 EBITDA from continuing operations $ 81.7 $ 48.1 Special items, before tax 43.2 82.0 Interest expense included in special items (2.2) (10.0) Depreciation and amortization included in special items — (0.8) Adjusted EBITDA $ 122.7 $ 119.3 Pro forma APM adjustments — 17.2 Pro forma adjusted EBITDA $ 122.7 $ 136.5 Pro forma adjusted EBITDA as a % of sales 16.3 % 15.4 % 1 Year Ended December 31, Reconciliation to EBITDA and Adjusted EBITDA: 2006 2018 Sales $ 2,622.4 $ 3,533.4 Net income from continuing operations – GAAP $ 133.5 $ 160.8 Income tax expense 29.7 36.4 Interest expense, net 63.1 62.8 Depreciation and amortization 57.1 91.5 EBITDA from continuing operations $ 283.4 $ 351.5 Special items, before tax (34.0) 59.5 Depreciation and amortization included in special items — (3.0) JV - equity income (107.0) — Adjusted EBITDA $ 142.4 $ 408.0 Adjusted EBITDA as a % of sales 5.4 % 11.5 % Reconciliation to EBITDA and Adjusted EBITDA: Three Months Ended December 31, 2022 Net loss from continuing operations – GAAP $ (16.6) Income tax benefit (60.8) Interest expense, net 49.4 Depreciation and amortization 48.6 EBITDA from continuing operations $ 20.6 Special items, before tax 104.3 Interest expense included in special items (16.0) Depreciation and amortization included in special items (1.5) Adjusted EBITDA $ 107.4 Reconciliation of Pro Forma Adjusted Earnings per Share: Three Months Ended December 31, 2022 Net loss from continuing operations attributable to Avient shareholders $ (17.0) Special items, after tax 38.3 Amortization expense, after-tax 14.6 Adjusted net income from continuing operations excluding special items 35.9 Pro forma adjustments* 2.5 Pro forma adjusted net income from continuing operations attributable to Avient shareholders $ 38.4 Weighted average diluted shares 91.7 Pro forma adjusted EPS - excluding special items pro forma for APM acquisition $ 0.42 * Pro forma adjustment to reflect APM results for the period before Avient ownership including the impacts of debt financing and paydown of debt with net proceeds from the Distribution sale. 2 AVNT Q3 2023 Earnings Presentation Avient corporation�Third quarter 2023 results DISCLAIMER Slide Number 3 Avient protective materials �First Year Slide Number 5 Slide Number 6 Slide Number 7 Slide Number 8 Slide Number 9 Slide Number 10 Slide Number 11 Slide Number 12 Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17 Slide Number 18 Slide Number 19 Slide Number 20 Slide Number 21 IR Deck - AVNT-2023.09.30 Non GAAP Recs Attachment
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Annual%2520Report%2520for%252017%2520Tideman.pdf
Orangeville Compound (Update 1) Report Preview National Pollutant Release Inventory (NPRI) and Partners Home Submission Management Help My Profile:Brian Greer Logout Ec.gc.ca Report Preview Report Details Company and Facility Details Permits Contacts Details Report Year 2016 Report Type: NPRI Report Status: Update 1 Submitted Modified Date/Time: 13/03/2018 2:04 PM Report Update Comments: As per email from NPRI QC team Feb 13, 2018 Company Name: Polyone Canada Inc.
Submitted Report Period Submission Date Facility Name Province City Programs 2016 13/03/2018 Orangeville Compound Ontario Orangeville NPRI Note: If there is a change in the contact information for the facility, a change in the owner or operator of the facility, if operations at the facility are terminated, or if information submitted for any previous year was mistaken or inaccurate, please update this information through SWIM or by contacting the National Pollutant Release Inventory directly. http://www.ec.gc.ca/default.asp?
https://www.avient.com/sites/default/files/2020-09/stan-tone-pep-et-product-bulletin.pdf
% Pigment Specific Gravity Color Index Lightfastness WHITE 10PEP03 Titanium Dioxide, Rutile 60 2.06 PW-6 I/O YELLOW 12PEP01 Diarylide AAOT GS 20 1.24 PY-14 I 12PEP03 Diarylide HR RS 25 1.23 PY-83 I/O (Mass) 13PEP02 Isoindolinone RS 25 1.31 PY-110 I/O 13PEP03 Benzimidazolone GS 25 1.25 PY-151 I/O (Mass) 81PEP01 Iron Oxide 60 2.07 PY-42 I/O ORANGE 15PEP03 Benzimidazolone RS 25 1.27 PO-36 I/O RED 23PEP04 Quinacridone BS 25 1.24 PV-19 I/O 23PEP06 Specialty Naphthol BS 25 1.23 PR-170 I/O (Mass) C 25PEP01 Red 2B, Ca Salt BS 17 1.26 PR-48:2 I/O (Mass) 28PEP01 Red 2B, Ba Salt YS 25 1.32 PR48:1 I/O (Mass) 82PEP01 Iron Oxide, Light YS 27 1.5 PR-101 I/O 82PEP02 Iron Oxide, Light BS 60 2.2 PR-101 I/O 82PEP04 Iron Oxide, Light VYS 60 2.2 PR-101 I/O 82PEP05 Iron Oxide, Dark VBS 60 2.21 PR-101 I/O BLUE 40PEP01 Phthalocyanine GS 25 1.27 PB-15:3 I/O 40PEP05 Phthalocyanine RS 25 1.27 PB-15 I/O 42PEP02 Ultramarine 35 1.44 PB-29 I/O 49PEP01 Cobalt 31 1.54 PB-28 I/O GREEN 50PEP01 Phthalocyanine BS 16 1.28 PG-7 I/O 50PEP03 Phthalocyanine YS 16 1.28 PG-7 I/O 59PEP02 Chromium Oxide 70 2.6 PG-17 I/O VIOLET/MAGENTA 24PEP03 Quinacridone Violet 20 1.24 PV-19 I/O 24PEP04 Ultramarine Violet 50 1.69 PV-15 I/O 24PEP05 Quinacridone Magenta 20 1.24 PR-122 I/O 24PEP06 Benzimidazolone 20 1.23 PV-32 I/O 24PEP07 Carbazole Violet 13 1.22 PV-23 I/O BROWN/TAN 83PEP01 Iron Oxide, Light 34 1.6 PBr-6 I/O 83PEP02 Iron Oxide, Dark 29 1.51 PBr-6 I/O BLACK 90PEP01 Furnace - High Jet 24 1.3 PBk-7 I/O 90PEP04 Furnace - Medium 17 1.27 PBk-7 I/O 90PEP05 Iron Oxide 33 1.58 PBk-11 I/O POLYESTER URETHANE PASTE COLORANTS (PEP) Stan-Tone Code Pigment Type Approx. % Pigment Specific Gravity Color Index Lightfastness WHITE 10ET03 Titanium Dioxide, Rutile 56 1.74 PW-6 I/O YELLOW 12ET01 Diarylide AAOT GS 40 1.15 PY-14 I 12ET03 Diarylide HR RS 20 1.07 PY-83 I/O (Mass) 13ET02 Isoindolinone RS 20 1.11 PY-110 I/O 13ET03 Benzimidazolone GS 20 1.08 PY-151 I/O (Mass) 81ET01 Iron Oxide 60 1.84 PY-42 I/O ORANGE 15ET03 Benzimidazolone RS 25 1.11 PO-36 I/O RED 20ET01 Red Lake C YS 30 1.16 PR-53 I 22ET01 Lithol Rubine BS 30 1.17 PR-57:1 I 23ET04 Quinacridone BS 15 1.05 PV-19 I/O 23ET06 Specialty Naphthol BS 30 1.09 PR-170 I/O (Mass) C 25ET01 Red 2B, Ca Salt BS 29 1.15 PR-48:2 I/O (Mass) 28ET01 Red 2B, Ba Salt YS 30 1.18 PR-48:1 I/O (Mass) 82ET01 Iron Oxide, Light BS 60 1.94 PR-101 I/O 82ET02 Iron Oxide, Dark VBS 60 1.95 PR-101 I/O 82ET04 Iron Oxide, Light VYS 60 1.94 PR-101 I/O BLUE 40ET01 Phthalocyanine GS 25 1.11 PB-15:3 I/O 40ET05 Phthalocyanine RS 20 1.09 PB-15 I/O 42ET02 Ultramarine 55 1.46 PB-29 I/O 49ET01 Cobalt 65 2.02 PB-28 I/O GREEN 50ET01 Phthalocyanine BS 30 1.2 PG-7 I/O 50ET03 Phthalocyanine YS 25 1.16 PG-7 I/O 59ET01 Chromium Oxide 65 2.12 PG-17 I/O VIOLET/MAGENTA 24ET03 Quinacridone Violet 20 1.08 PV-19 I/O 24ET04 Ultramarine Violet 60 1.66 PV-15 I/O 24ET05 Quinacridone Magenta 20 1.08 PR-122 I/O 24ET06 Benzimidazolone 25 1.08 PV-32 I/O 24ET07 Carbazole Violet 13 1.05 PV-23 I/O BROWN/TAN 83ET01 Iron Oxide, Light 64 2.02 PBr-6 I/O 83ET02 Iron Oxide, Dark 60 1.9 PBr-6 I/O BLACK 90ET04 Furnace - Medium 22 1.12 PBk-7 I/O 90ET05 Iron Oxide 60 1.9 PBk-11 I/O POLYETHER URETHANE PASTE COLORANTS (ET) PEP/ET RS = Red Shade YS = Yellow Shade VYS = Very Yellow Shade BS = Blue Shade VBS = Very Blue Shade GS = Green Shade HR = Heat-Resistant LIGHTFASTNESS I = Indoor Only I/O = Indoor or Outdoor Mass = Outdoor Masstone Application Only C = Some Caution Advised www.avient.com Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2021-11/avient-th.-bergmann-gmbh-cr-extract-nov-8-2021.pdf
Geschäftsführer: Katsers, Guy, Brülle/Belgien, *26.06.1950 Geschäftsführer: Mohn, Christopher, Lasne/Belgien, *11.06.1955 a) Gesellschaft mit beschränkter Haftung Gesellschaftsvertrag vom 24.02.1994, mehrfach geändert zuletzt geändert am 20.11.2001 b) Zwischen der Gesellschaft als beherrschtem Unternehmen und der Firma "Hanna Deutschland GmbH" in Gaggenau ist am 13.
Dezember 1994 mit Zustimmung der Gesellschafterversammlung vom 13.
https://www.avient.com/sites/default/files/2022-01/NAI_1525166563_1_Poland_8B.d_Extract %28new name branch%29.PDF
CENTRALNA INFORMACJA KRAJOWEGO REJESTRU SĄDOWEGO KRAJOWY REJESTR SĄDOWY Stan na dzień 23.12.2021 godz. 13:27:52 Numer KRS: 0000748363 Informacja odpowiadająca odpisowi aktualnemu Z REJESTRU PRZEDSIĘBIORCÓW Data rejestracji w Krajowym Rejestrze Sądowym 11.09.2018 Ostatni wpis Numer wpisu 11 Data dokonania wpisu 23.12.2021 Sygnatura akt LD.XX NS-REJ.KRS/33915/21/474 Oznaczenie sądu SĄD REJONOWY DLA ŁODZI ŚRÓDMIEŚCIA W ŁODZI, XX WYDZIAŁ GOSPODARCZY KRAJOWEGO REJESTRU SĄDOWEGO Dział 1 Rubryka 1 Dane podmiotu 1.Oznaczenie formy prawnej ODDZIAŁ ZAGRANICZNEGO PRZEDSIĘBIORCY 2.Numer REGON/NIP REGON: 381279490, NIP: --- 3.Nazwa AVIENT S.A R.L.
Podrubryka 1 Dane osób wchodzących w skład organu 1 1.Nazwisko / Nazwa lub firma KRONIMUS 2.Imiona HOLGER HANS 3.Funkcja w organie reprezentującym ZARZĄDZAJĄCY 2 1.Nazwisko / Nazwa lub firma PALM 2.Imiona CHRISTOPH 3.Funkcja w organie reprezentującym ZARZĄDZAJACY 3 1.Nazwisko / Nazwa lub firma POTOCZNY 2.Imiona ŻANETA GABRIELA 3.Funkcja w organie reprezentującym ZARZĄDZAJACY 4 1.Nazwisko / Nazwa lub firma MERKLEIN 2.Imiona NORBERT 3.Funkcja w organie reprezentującym ZARZĄDZAJĄCY Rubryka 2 Organ nadzoru Brak wpisów Rubryka 3 Prokurenci Brak wpisów Rubryka 4 Osoby reprezentujące zagranicznego przedsiębiorcę w oddziale 1 1.Nazwisko DROJMA 2.Imiona KAMIL RAFAŁ Strona 2 z 5 3.Numer PESEL 85072613192 4.Funkcja w oddziale Dział 3 Rubryka 1 Przedmiot działalności 1.Przedmiot przeważającej działalności przedsiębiorcy 1 20, 12, Z, PRODUKCJA BARWNIKÓW I PIGMENTÓW 2.Przedmiot pozostałej działalności przedsiębiorcy 1 20, 16, Z, PRODUKCJA TWORZYW SZTUCZNYCH W FORMACH PODSTAWOWYCH 2 22, 2, , PRODUKCJA WYROBÓW Z TWORZYW SZTUCZNYCH 3 22, 22, Z, PRODUKCJA OPAKOWAŃ Z TWORZYW SZTUCZNYCH 4 22, 23, Z, PRODUKCJA WYROBÓW DLA BUDOWNICTWA Z TWORZYW SZTUCZNYCH 5 22, 29, Z, PRODUKCJA POZOSTAŁYCH WYROBÓW Z TWORZYW SZTUCZNYCH 6 22, 21, Z, PRODUKCJA PŁYT, ARKUSZY, RUR I KSZTAŁTOWNIKÓW Z TWORZYW SZTUCZNYCH 7 70, 22, , POZOSTAŁE DORADZTWO W ZAKRESIE PROWADZENIA DZIAŁALNOŚCI GOSPODARCZEJ I ZARZĄDZANIA 8 68, 10, Z, KUPNO I SPRZEDAŻ NIERUCHOMOŚCI NA WŁASNY RACHUNEK 9 68, 20, Z, WYNAJEM I ZARZĄDZANIE NIERUCHOMOŚCIAMI WŁASNYMI LUB DZIERŻAWIONYMI Rubryka 2 Wzmianki o złożonych dokumentach Rodzaj dokumentu Nr kolejny w polu Data złożenia Za okres od do 1.Wzmianka o złożeniu rocznego sprawozdania finansowego 1 20.02.2020 OD 11.09.2018 DO 31.12.2018 2 21.07.2021 OD 01.01.2019 DO 31.12.2019 3 10.09.2021 OD 01.01.2020 DO 31.12.2020 2.Wzmianka o złożeniu opinii biegłego rewidenta / sprawozdania z badania rocznego sprawozdania finansowego 1 ***** OD 01.01.2019 DO 31.12.2019 2 ***** OD 01.01.2020 DO 31.12.2020 3.Wzmianka o złożeniu uchwały lub postanowienia o zatwierdzeniu rocznego sprawozdania finansowego 1 ***** OD 01.01.2019 DO 31.12.2019 2 ***** OD 11.09.2018 DO 31.12.2018 Rubryka 3 Brak wpisów Rubryka 4 Przedmiot działalności statutowej organizacji pożytku publicznego Brak wpisów Rubryka 5 Informacja o dniu kończącym rok obrotowy 1.Dzień kończący pierwszy rok obrotowy, za który należy złożyć sprawozdanie finansowe 31.12.2018 Strona 3 z 5 Dział 4 Rubryka 1 Zaległości Brak wpisów Rubryka 2 Wierzytelności Brak wpisów Rubryka 3 Informacje o oddaleniu wniosku o ogłoszenie upadłości na podstawie art. 13 ustawy z 28 lutego 2003 r.
https://www.avient.com/sites/default/files/2021-02/avient-ir-presentation-goldman-sachs-and-morgan-stanley.pdf
Q 4 AN D FU LL Y EA R 2020 PE RF O RM AN CE $0.30 $0.52 2019 PF 2020 Q4 2020 ORGANIC PERFORMANCE 9 Sales $922 $997 2019 PF 2020 +8% Adjusted Operating Income Adjusted EPS $58 $80 2019 PF 2020 +38% +73% • Record 4th quarter sales, adjusted operating income and adjusted EPS performance • All segments delivered year-over-year sales and operating income growth, led by consumer and healthcare end markets • Clariant Masterbatch integration synergy capture ahead of schedule: $5 million realized in 2020 ($ in millions except EPS) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Q4 2020 SEGMENT PERFORMANCE 10 Sales Operating Income $100 $100 $100 $922 $100 $100 $100 $997 Distribution CAI SEM Total 2019 2020 $178 $272 $490 $191 $305 $526 SEM Distribution CAI 2019PF 2020 +8% +7% +7% +12% $5 $5 $5 $58 $5 $5 $5 $80 Avient CAI SEM Total 2019 PF 2020 $17 $19 $40 $18 $30 $58 Distribution SEM CAI 2019PF 2020 +38% +45% +58% +6% (3) (3) ($ in millions) (1) (2) (1) Total company sales include intercompany sales eliminations (2) Total company reflects adjusted operating income and includes corporate costs (3) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 2020 HIGHLIGHTS 11 • Completed transformational Clariant Masterbatch acquisition and created new brand name Avient • Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier during the pandemic and due to growth in demand for consumer applications • Specialty Engineered Materials delivered record operating income on gains from composites • Achieved record free cash flow, increased dividend for 10th year in a row and delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA • Culture is everything: Certified as a Great Place to Work® $133 $150 2019PF 2020PF 10% 23%8% 21% 4% 15% 2006 2020PF Healthcare Consumer Packaging Avient Portfolio Transformation 22% 59% CLARIANT MASTERBATCH: TRANSFORMATIONAL ACQUISITION 12 Clariant MB EBITDA Growth Purchase Price Multiple 10.8 9.6 6.5 2019PF 2020PF 2020PF w/ Full Synergies x x x • Acquisition of Clariant Masterbatch significantly expands presence in healthcare, packaging and consumer end markets • Strength of portfolio – 13% EBITDA growth as an essential supplier in COVID response and recovery • Acquisition completed on July 1, 2020 for $1.4 billion.
Purchase price multiple rapidly declining on strength of business and synergy capture (1) (1) (1) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition ($ in millions) 13 SEM CAI Avient • Composites and Outdoor High Performance applications drove positive mix within SEM • Clariant Masterbatch synergy realization under way and expected to drive further margin expansion in 2021 • Portfolio transformation to high growth end markets with focus on sustainable solutions megatrend 10.1% 11.8% 2019PF 2020 (1) (1) EBITDA MARGIN EXPANSION Distribution 6.3% 6.0% 15.2% 17.6% 11.1% 12.1% 2019PF 2020PF 14.5% 19.8% 13.5% 16.1% 6.4% 6.3% 15.2% 16.2% (1) (1) Full YearQ4 (2) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (2) Total company reflects adjusted EBITDA margins SPOTLIGHT: COMPOSITES 14 • SEM delivers a record year in 2020 – 13% operating income growth and over 200 bps in margin expansion year-over-year • Prior investments in composites platform and outdoor high performance applications paying off, resulting in substantial growth over the last two years SEM Operating Income (OI % of Sales) ($ in millions) $(0.1) $(1.0) $2.2 $19.1 $26.8 2016 2017 2018 2019 2020 Composites Performance (Operating Income) $83.7 $94.4 2019 2020 (11.2%) (13.3%) 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 11 12 13 14 15 16 17 18 19 20 $19 $160 $338 2011 2019 2020 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 11 12 13 14 15 16 17 18 19 20 21E FREE CASH FLOW AND CAPITAL ALLOCATION 15 Free Cash Flow Dividends Share Repurchases Deleveraging 3.5x 2.7x 2019PF 2020PF Growing Dividend Cumulative Buybacks Net Leverage $B n $ p e r sh ar e Cash Generation (1) (1) ~$1Bn REPURCHASED OVER LAST 10 YEARS ~$350MM PAID OVER LAST 10 YEARS ~$338MM 2.7x NET LEVERAGE (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition GREAT PLACE TO WORK!
SEGMENT HIGHLIGHTS U.S. & Canada 50% EMEA 26% Asia 16% Latin America 8% 2020 SEGMENT, END MARKET AND GEOGRAPHY 30 GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 23% Packaging 21%Industrial 15% Wire & Cable 6% Building & Construction 6% Electrical & Electronics 4% END MARKET REVENUE Transportation 10% Healthcare 15% All data reflects 2020 Pro forma for acquisition of the Clariant Masterbatch business. (1) The total company sales and EBITDA of $3,783M and $457M, respectively, include intercompany sales eliminations and corporate costs $2,043M $331M $709M $124M $1,110M $70M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $457M$3,783M (1) Packaging 35% Consumer 23% Healthcare 8% Industrial 14% Building & Construction 8% Transportation 7% Wire & Cable 3% Electrical & Electronics 2% C O L O R , A D D I T I V E S & I N K S 2020 PF REVENUE | $2 .0 BILLION US & Canada 31% EMEA 40% Asia 22% Latin America 7% END MARKET REGION 31 2020 figures Pro forma for acquisition of the Clariant Masterbatch business S P E C I A LT Y E N G I N E E R E D M AT E R I A L S Consumer 24% Healthcare 10% Packaging 6% Wire & Cable(1) 24% Electrical & Electronics 13% Transporation 11% Industrial 10% Building & Construction 2% 2020 REVENUE | $709 MILLION END MARKET US & Canada 58% EMEA 23% Asia 19% REGION 32 (1) Approximately 50% of Wire and Cable sales are associated with Fiber Optic Cabling DI S TR IBU T I ON 2020 REVENUE | $1 .1 B ILL ION Healthcare 29% Consumer 25% Packaging 2% Industrial 20% Transportation 14% Electrical & Electronics 5% Building & Construction 4% Wire & Cable 1% US & Canada 82% Asia 3% Latin America 15% END MARKET REGION K E Y S U P P L I ER S 33 AMERICAS EMEA ASIA Consumer 26% Healthcare 19% Packaging 13% Industrial 16% Wire & Cable 7% Building & Construction 5% Electrical & Electronics 4% Packaging 34% Consumer 16%Healthcare 5% Industrial 17% Wire & Cable 10% Building & Construction 8% Electrical & Electronics 3% Packaging 32% Consumer 27% Healthcare 12% Industrial 6% Wire & Cable 6% Building & Construction 4% Electrical & Electronics 9% Transportation 10% Transportation 7% Transportation 4% 2020 figures Pro forma for acquisition of the Clariant Masterbatch business TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET (58% of sales) (26% of sales) (16% of sales) 34 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2022-05/AVNT May IR Presentation w Non GAAP Recs.pdf
WHAT WE DO: MATERIAL SCIENCE 5 CUSTOM FORMULATION SUSTAINABILITY FOR A BETTER TOMORROW Revenue From Sustainable Solutions* 2016-2021 $310 205 140 80 75 45 40 20 $915M2021 Sales ($ in millions) *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Color business Future Growth Revenue Assumptions From Sustainable Solutions: 8 - 12% 6 AVIENT ESG RATINGS Sustainalytics 2021 ESG Risk Ranking RANK (1st = lowest risk) PERCENTILE (1st – lowest risk) Chemicals INDUSTRY 75/449 17th Specialty Chemicals SUBINDUSTRY 21/124 17th ISS March 2022 ESG Scores SCORE (1 = Best, 10 = Worst) Environmental 2 Social 1 Governance 4 777 F I RS T Q UART E R 2022 RE S U LT S $123 $136 2021 2022 $0.89 $0.99 2021 2022 Q1 2022 PERFORMANCE (TOTAL COMPANY) 9 $1,162 $1,294 2021 2022 + 11% (+ 14% excluding FX) Adjusted EPS + 11% (+ 15% excluding FX) + 11% (+ 16% excluding FX) (in millions) (in millions) Sales Adjusted Operating Income Q1 2022 SEGMENT PERFORMANCE 10 CAI $609 $650 Sales ($ in millions) SEM Distribution $89 $95 Operating Income + 7% (+ 10% excluding FX) $363 $433 Sales $24 $24 Operating Income + 19% Flat (1) $217 $245 Sales $34 $40 Operating Income + 7% (+ 11% excluding FX) + 13% (+ 17% excluding FX) + 18% (+ 20% excluding FX) Q1 2021 $1,162 $123 Sustainable Solutions 19 8% 7 Healthcare 32 21% 6 Composites (excl.
Outdoor High Performance) 8 18% 3 Growth in Asia / LATAM 6 3% 2 Other 100 19% 5 Sub-total $1,327 14% $146 Outdoor High Performance Impact (5) (3) Wage Inflation and Overtime (11) Other Supply Chain Costs (4) Synergies 5 Incentives, Other Employee Costs 8 FX (28) (5) Q1 2022 $1,294 11% $136 Q1 2022 SALES AND OPERATING INCOME (TOTAL COMPANY) 11 Sales Growth Rate Adjusted Operating Income$ millions Adjusted EBITDA Q1 EBITDA BRIDGE 12 Price increases more than offset raw material and supply chain impacts Q1 2021 $ 161 Demand (23) $ millions CAI: Price / Mix 77 Inflation (54) SEM: Price / Mix 41 Inflation (26) Distribution: Price / Mix 84 Inflation (82) Net Price Benefit 40 Wage Inflation and Overtime (11) Other Supply Chain Costs (4) Synergies 5 Incentives, Other Employee Costs 8 FX (5) Q1 2022 $ 171 China Lockdowns / Russia Impact $ (7) Transportation (7) Outdoor High Performance (3) Q1 EPS BRIDGE 13 Q1 2021 - Adjusted EPS 0.89$ CAI 0.08 Specialty Engineered Materials 0.06 Distribution 0.00 Corporate Costs 0.02 F/X (0.04) Segment OI 0.12 Tax Rate (0.02) Q1 2022 - Adjusted EPS 0.99$ 2022 O U T LO O K REVENUE GROWTH DRIVERS Growth Drivers Long-Term Growth Rate 2022E Growth Rate Sustainable Solutions 8–12% 12% Healthcare 8–10% 10% Composites 10% 5% Asia / LATAM 5% 5% Other (GDP growth) 2–3% 2–3% Avient 6.5% 6% 15 Excluding Outdoor High Performance 20% (8% excl.
OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 9.8 13.8 12.8 12.1 11.8 10.2 21.0 19.2 16.8 13.7 13.6 8.8 8.7 8.7 8.3 8.0 5.6 Av ie nt (2 01 1) Av ie nt (2 01 6) Av ie nt (2 02 1) Av ie nt (T od ay ) R PM PP G KW R AV Y FU L AL B EC L H XL AS H FM C BN R EM N U N VR C E SC L H U N Historic Multiple APPENDIX Performance Additives 15% Pigments 13% TiO2 11% Dyestuffs 3%Polyethylene 12% Nylon 6% Polypropylene 5% Other Raw Materials 30% Styrenic Block Copolymer 5% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 48 • Significant raw material price inflation and tight inventory continued in Q1 2022 o The average cost of hydrocarbon based materials was up 30% o The average cost of non-hydrocarbon based materials was up 20% • Additionally, we continued to experience other supply chain challenges during Q1 related to raw material spot purchases, freight constraints and productivity loss as a result of these shortages Annual Purchases RAW MATERIAL AND SUPPLY CHAIN UPDATE Based on 2021 purchases, excludes Distribution business SEGMENT DATA U.S. & Canada 50% EMEA 25% Asia 16% Latin America 9% 2021 SEGMENT, END MARKET AND GEOGRAPHY 50 GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 23% Packaging 19% Industrial 16% Building and Construction 10% Telecommunications 4% Energy 2% END MARKET REVENUE (1) Total company sales and adjusted EBITDA of $4,819M and $581M, respectively, include intercompany sales eliminations and corporate costs $2,402M $409M $919M $164M $1,631M $94M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $581M$4,819M (1) Transportation 11% Healthcare 15% Packaging 34% Consumer 21% Healthcare 8% Industrial 16% Building & Construction 10% Transportation 9% Energy 1% Telecommunications 1% C O L O R , A D D I T I V E S & I N K S 2021 REVENUE | $2 .4 BILLION US & Canada 32% EMEA 40% Asia 21% Latin America 7% END MARKET REGION 51 All charts reflect 2021 financials S P E C I A LT Y E N G I N E E R E D M AT E R I A L S Consumer 27% Healthcare 10% Packaging 7% Telecommunications 16% Transportation 11% Industrial 11% Building & Construction 11% Energy 7% 2021 REVENUE | $919 MILLION END MARKET US & Canada 55% EMEA 25% Asia 20% REGION 52 All charts reflect 2021 financials DI S T RI BU T I O N Healthcare 26% Consumer 23% Packaging 5% Industrial 20% Transportation 16% Building and Construction 8% Energy 1% Telecommunications 1% US & Canada 80% Asia 3% Latin America 17% END MARKET REGION K EY SU PPL IER S 2021 REVENUE | $1 .6 BILLION 53 All charts reflect 2021 financials TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET Packaging 30% Consumer 26%Healthcare 13% Industrial 14% Building & Construction 5% Telecommunications 2% Energy 2% Asia (16% of sales) Transportation 8% Packaging 32% Consumer 13% Healthcare 5% Industrial 17% Building & Construction 12% Telecommunications 5% Energy 4% EMEA (25% of sales) Transportation 12% 54 Consumer 25% Healthcare 19% Packaging 10% Industrial 17% Building & Construction 10% Telecommunications 4% Energy 2% US & Canada (50% of sales) Transportation 13% Packaging 38% Consumer 33% Healthcare 8% Industrial 10% Building & Construction 5% Telecommunications 1% LATAM (9% of sales) Transportation 5% All charts reflect 2021 financials Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/knowledge-base/article/injection-molding-mold-design?rtype[]=1164
H-13
Figure 13 shows a typical design of a submarine gate.